William Hinshaw - Oct 17, 2022 Form 4 Insider Report for Axcella Health Inc. (AXLA)

Role
President & CEO, Director
Signature
By: /s/ Paul Fehlner, Attorney-in-Fact
Stock symbol
AXLA
Transactions as of
Oct 17, 2022
Transactions value $
-$25,027
Form type
4
Date filed
10/19/2022, 06:49 PM
Previous filing
Mar 18, 2022
Next filing
Feb 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXLA Common Stock Award +50K +104.14% 98K Oct 17, 2022 Direct F1
transaction AXLA Common Stock Sale -$25K -16K -16.32% $1.56* 82K Oct 19, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 29, 2020, the Reporting Person was granted 50,000 restricted stock units ("RSUs"), which vest upon satisfaction of certain performance criteria. On October 17, 2022, the Issuer's Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such RSUs.
F2 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.52 to $1.62. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.